The features identified by the model are reflected in the ESC guidelines for stratifying patients into risk groups, including blood NT-proBNP concentration, 6-min walk test result, TAPSE to sPAP ratio [17,18], and the presence of pericardial effusion. This evidence concerns the gene NPPB and pericardial effusion.